Colorado Dangerous Drugs & Medical Devices

Fosamax®

Burg Simpson is not currently pursuing new Fosamax® cases.

Millions of Americans are prescribed Fosamax to help improve their bone density and fight osteoporosis. However, evidence suggests that Fosamax and its generic equivalent (alendronate), may actually be doing more harm than good and may be the cause of unusual and painful low-energy fractures of the femur (thigh bone).

FOSAMAX LINKED TO ATYPICAL FEMUR FRACTURES

Originally approved in 1995, Fosamax® is manufactured by Merck & Co, Inc. and belongs to a family of drugs know as bisphosphonates. Bisphosphonates are routinely prescribed to post-menopausal women and other individuals who are known to be at a high-risk of bone density deterioration.

In 2008, the results of an observational study, published in the Journal of Orthopedic Trauma, linked Fosamax® to a distinct type of fracture in the femur. The study of some 70 patients experiencing low-energy femur fractures (which occur when someone falls from a standing height or less) revealed that these patients all suffered a similar and distinct straight-line fracture of their femur. Furthermore, of the patients studied, more than a third had been taking Fosamax® for an average of five years or more.

PROLONGED USE OF FOSAMAX® MAY PUT WOMEN AT HIGHER RISK

Since the findings of that 2008 study, it would appear that orthopedic surgeons and bone specialists are continuing to see more and more of these unusual fractures among long-term users of Fosamax®, particularly in women. In February 2011, the results of a Canadian study, published in the online edition of the Journal of the American Medical Association suggested that women who had been on bisphosphonates such as Fosamax® for more than five years, had nearly three times higher risk of these unusual fractures than those with only transient exposure to the drugs.

FOSAMAX® AND OSTEONECROSIS OF THE JAW (ONJ; DEAD JAW)

In addition to causing potential femur fractures, prolonged use of Fosamax® and other bisphosphonates have long been linked to a rare condition that involves the loss, or breakdown, of the jaw bone called osteonecrosis of the jaw (ONJ) or dead jaw. In early 2005 the FDA requested that Merck and all other bisphosphonate manufacturers revise the Fosamax warning label to include a warning that their drugs may be related to the onset of ONJ. Osteonecrosis appears to occur when the bone tissue of the jaw fails to heal properly from any trauma that causes the jawbone to be exposed in the mouth. For example, this type of exposure can occur from something as simply as a tooth extraction. Once the jawbone begins to die, treatment generally focuses on eradicating infection and relieving pain. More aggressive treatments may include removing large portions of dead bone. The development of Osteonecrosis is associated with the use of Fosamax or other bisphosphonates.

Subsequent studies now suggested that Fosamax and other bisphoshonates might also lead to a breakdown and deterioration of bone tissue in the knee shoulder joints.

FLORIDA WOMAN AWARDED $8 MILLION FOR FOSAMAX® INJURIES

In 2010, a NYC jury awarded a Fosamax® user $8 million, finding that Fosamax® caused her ONJ. The case is In re Fosamax Products Liability Litigation, U.S. District Court, Southern District of New York (Manhattan), No. 06-1789.

FDA SAFETY WARNINGS

At the present time, FDA has not seen fit to issue a nationwide recall of Fosamax® or any of its generic equivalents and the drugs still remains commercially available. However, the FDA has issued numerous other warnings and consumer safety communications regarding bisphosphonates.

Fosamax® is a registered trademark of Merck & Co., Inc.

 

 June 12, 2019

Burg Simpson to Sponsor the 7th Annual Jeremy Bitner Memorial Run!

Burg Simpson is proud to sponsor the 7th annual Jeremy Bitner Memorial Run. The Jeremy Bitner Foundation was established in honor of Englewood Police Detective Jeremy Bitner after he lost his life in the line of duty in 2012. Burg Simpson shareholder Nick Fogel, the practice group leader of the firm’s workers’ compensation department, helped to develop the… Read more »

Ohio Attorney Kenneth Daly hero image

 May 23, 2019

Kenneth M. Daly Now Licensed to Practice in the State of Kentucky

Kenneth M. Daly Now Licensed to Practice in the State of Kentucky Kentucky Just Got Lucky! Burg Simpson is pleased to announce that Kenneth Daly, an attorney in the firm with an established practice in Ohio, recently passed the Kentucky bar. Kenneth is excited about the opportunity to expand his practice to include the citizens of… Read more »

Ohio Attorney Melanie S. Bailey hero image

 May 22, 2019

Melanie S. Bailey Published in Cincinnati Bar Association Report

Melanie S. Bailey Published in Cincinnati Bar Association Report Melaine S. Bailey authored an article published in the CBA Report regarding the ability of consumers to hold drug manufacturers liable for failure to warn of adverse reactions to prescription medications. In the article, Brand Name Drug or Generic Drug: Generic may foil your client’s failure to warn… Read more »

Swearing In Ceremony

 May 15, 2019

Burg Simpson Congratulates Ms. Jessica Powell, Esq.

Burg Simpson Congratulates Ms. Jessica Powell, Esq. Congratulations to Jessica Powell on her admission to the practice of law in the State of Ohio! Ms. Jessica Powell, an associate at Burg Simpson in Cincinnati, OH, was sworn in at the Admissions Ceremony on May 13, 2019. Pictured is Ms. Jessica Powell at the Admissions Ceremony. Jessica… Read more »

The 2019 Burg Simpson Scholarship Awards Dinner

 May 7, 2019

The 2019 Burg Simpson Scholarship Awards Dinner

The 2019 Burg Simpson Scholarship Awards Dinner was held at Maggiano’s on April 25th to recognize the ten winners of the firm’s annual scholarship competition. The firm’s founder Michael Burg, and shareholders Peter Burg and Stephan Marsh presented awards to the 2019 winners! This year’s recipients included Ms. Madison Frotten, Mr. Dale Kim, Ms. McKenna… Read more »

Burg Simpson | Workers’ Compensation

 April 17, 2019

Burg Simpson | Workers’ Compensation

Shareholder Nick Fogel is the practice group leader of the Workers’ Compensation division at Burg Simpson. Workers’ Compensation is a form of insurance that protects employees when they are injured on the job or in the line of duty. Workers’ compensation provides both wage replacement and medical benefits. Filing a workers’ compensation claim can be… Read more »

Burg Simpson | We Are Here To Help

 April 5, 2019

Burg Simpson | We Are Here To Help

Burg Simpson is a law firm committed to helping injured people rebuild their lives after a serious accident or injury. Our trial lawyers have handled nearly every kind of injury or wrongful death case. The team at Burg Simpson has the resources, nationwide reputation, or proven track record of success when it comes to helping… Read more »

Becoming Whole Again

 April 4, 2019

Becoming Whole Again

If you or a loved one has suffered a loss due to an injury or death because of the negligence of another, you are entitled to receive full and fair compensation for your pain and suffering. Burg Simpson’s office in Arizona can help you navigate your personal injury claim. Burg Simpson attorney, Scott A. Ambrose… Read more »

Top 100 National Trial Lawyers Legal 500 Best Lawyers in America Super Lawyers US News 2014 Top 25 Most Influential Lawyers